Clinical Trial

Nuvascular Harbor Occlusion Device Pilot Study

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the safety and effectiveness of the HARBOR Occlusion Device for treating brain aneurysms. The HARBOR Device is investigational (experimental), meaning the Regulatory Authorities have not approved it for commercial use. The data collected in this research study will be used to analyze whether the HARBOR Device is safe and effective in treating brain aneurysms.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-05; most recent amendment 2026-03-14.
Status change: Recruiting → Active, Not Recruiting 2026-03-14
Status change: Not Yet Recruiting → Recruiting 2025-12-31
Trial Details
NCT Number NCT07117526
Lead Sponsor Nuvascular Inc
Conditions Intracranial Arterial Aneurysm
Enrollment 10 participants
Start Date 2025-10-01
Primary Completion 2027-03 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-17